R J McKendry

2.2k total citations
37 papers, 1.6k citations indexed

About

R J McKendry is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, R J McKendry has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in R J McKendry's work include Rheumatoid Arthritis Research and Therapies (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). R J McKendry is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). R J McKendry collaborates with scholars based in Canada, United States and United Kingdom. R J McKendry's co-authors include G Kraag, Theodore Pincus, David E. Yocum, John Tesser, Peter Tugwell, Oscar Gluck, Michael Ashley Stein, George A. Wells, Anwar Al‐Awadhi and Hans K. Uhthoff and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

R J McKendry

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R J McKendry Canada	20	900	361	279	251	234	37	1.6k
Richard Brasington United States	22	868 1.0×	195 0.5×	142 0.5×	191 0.8×	125 0.5×	41	1.7k
Carine Salliot France	21	1.5k 1.6×	639 1.8×	325 1.2×	290 1.2×	329 1.4×	63	2.5k
E. J. ter Borg Netherlands	24	1.6k 1.8×	364 1.0×	178 0.6×	143 0.6×	200 0.9×	46	2.2k
T B Wallington United Kingdom	17	513 0.6×	275 0.8×	268 1.0×	155 0.6×	148 0.6×	43	1.4k
R. Rau Germany	20	1.2k 1.4×	440 1.2×	218 0.8×	162 0.6×	65 0.3×	49	1.5k
C.J. Haagsma Netherlands	20	2.0k 2.3×	855 2.4×	445 1.6×	266 1.1×	120 0.5×	38	2.8k
Piero Marson Italy	24	380 0.4×	418 1.2×	152 0.5×	260 1.0×	146 0.6×	101	1.4k
F Mignon France	22	402 0.4×	172 0.5×	234 0.8×	161 0.6×	108 0.5×	70	1.9k
Beverley Harrison United Kingdom	20	1.5k 1.7×	479 1.3×	157 0.6×	94 0.4×	92 0.4×	29	1.9k
Soo‐Kyung Cho South Korea	23	989 1.1×	178 0.5×	128 0.5×	213 0.8×	205 0.9×	133	1.7k

Countries citing papers authored by R J McKendry

Since Specialization

Citations

This map shows the geographic impact of R J McKendry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J McKendry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J McKendry more than expected).

Fields of papers citing papers by R J McKendry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J McKendry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J McKendry. The network helps show where R J McKendry may publish in the future.

Co-authorship network of co-authors of R J McKendry

This figure shows the co-authorship network connecting the top 25 collaborators of R J McKendry. A scholar is included among the top collaborators of R J McKendry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J McKendry. R J McKendry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McKendry, R J, et al.. (2005). Treatment and Outcomes of Diabetic Muscle Infarction. JCR Journal of Clinical Rheumatology. 11(1). 8–12. 52 indexed citations

Brunet, Jacques A., et al.. (2004). Diabetic muscle infarction: case report and review.. PubMed. 31(1). 190–4. 64 indexed citations

Cranney, Ann, R J McKendry, G A Wells, et al.. (2001). The effect of low dose methotrexate on bone density.. PubMed. 28(11). 2395–9. 62 indexed citations

Stein, C. Michael, Theodore Pincus, David E. Yocum, et al.. (1997). Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension study. Arthritis & Rheumatism. 40(10). 1843–1851. 65 indexed citations

McKendry, R J. (1997). THE REMARKABLE SPECTRUM OF METHOTREXATE TOXICITIES. Rheumatic Disease Clinics of North America. 23(4). 939–954. 61 indexed citations

McKendry, R J, G. A. H. Wells, Peter Dale, et al.. (1996). Factors influencing the emigration of physicians from Canada to the United States.. PubMed. 154(2). 171–81. 21 indexed citations

Tugwell, Peter, Theodore Pincus, David E. Yocum, et al.. (1995). Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis. New England Journal of Medicine. 333(3). 137–142. 375 indexed citations

Freeman, Colbey W., et al.. (1994). Use of magnetic resonance imaging in diagnosing eosinophilic fasciitis. report of two cases. Arthritis & Rheumatism. 37(11). 1602–1608. 21 indexed citations

Jordan, David R., et al.. (1993). Orbital Panniculitis as the Initial Manifestation of Systemic Lupus Erythematosus. Ophthalmic Plastic and Reconstructive Surgery. 9(1). 71–75. 19 indexed citations

10.

McKendry, R J, et al.. (1993). Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.. PubMed. 20(11). 1850–6. 107 indexed citations

11.

McKendry, R J, et al.. (1993). Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis.. Annals of the Rheumatic Diseases. 52(11). 826–828. 43 indexed citations

12.

Willkens, Robert F., Murray B. Urowitz, Donald M. Stablein, et al.. (1992). Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. Arthritis & Rheumatism. 35(8). 849–856. 94 indexed citations

13.

Coffman, Jay D., Mark A. Creager, John Dormandy, et al.. (1989). International study of ketanserin in Raynaud's phenomenon. The American Journal of Medicine. 87(3). 264–268. 32 indexed citations

14.

Sengar, D.P.S., R J McKendry, & Hans K. Uhthoff. (1989). Lack of association between HLA and rotator cuff rupture. Tissue Antigens. 34(3). 205–206.

15.

Hamdy, Hany, et al.. (1987). Low‐dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. a twenty‐four—week controlled clinical trial. Arthritis & Rheumatism. 30(4). 361–368. 88 indexed citations

16.

McKendry, R J, et al.. (1987). Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.. PubMed. 14(6). 1164–71. 170 indexed citations

17.

McKendry, R J. (1987). Influence of Age at Onset on the Duration of Treatment in Idiopathic Adult Polymyositis and Dermatomyositis. Archives of Internal Medicine. 147(11). 1989–1989. 5 indexed citations

18.

Goldstein, Rose, et al.. (1985). Diagnostic and predictive value of the lupus band test in undifferentiated connective tissue disease. A followup study.. PubMed. 12(6). 1093–6. 2 indexed citations

19.

McKendry, R J, et al.. (1983). Acne, arthritis and sacroiliitis.. PubMed. 128(2). 156–8. 7 indexed citations

20.

Foss, Brynjar, et al.. (1981). Effects of prostaglandins E1 and E2 on the in vitro production of immunoglobulin by human peripheral blood lymphocytes. Prostaglandins and Medicine. 6(4). 419–425. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact